Daegu
South Korea
32
2025-10-02
The entities that hold a legal rights for patent applications filed by inventor BAE Jae-Sung:
Jae-Sung BAE from Daegu, KR has applied for patents for these inventions. The list has both pending applications and granted patents:
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASE, CONTAINING, AS ACTIVE INGREDIENTS, CYCLODEXTRIN AND STEM CELLS IN WHICH VEGF IS OVEREXPRESSED
#2 | 2025-08-28COMPOSITION FOR DIAGNOSING DISEASES ASSOCIATED WITH COX2 OVEREXPRESSION AND SCREENING METHOD THEREFOR
#3 | 2025-07-10ANTIBODY SPECIFICALLY BINDING TO ASM AND USE THEREOF
#4 | 2024-08-01PHARMACEUTICAL COMPOSITION FOR TREATING BRAIN DISEASES COMPRISING ANTIBODY SPECIFICALLY BINDING TO ASM PROTEIN AS ACTIVE INGREDIENT
#5 | 2024-04-18PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES COMPRISING COX2 ACETYLATING AGENT AS ACTIVE INGREDIENT
#6 | 2023-10-26USE OF TRIAZOLE COMPOUND AS GHRELIN RECEPTOR AGONIST
#7 | 2023-04-27ANTIBODY FOR DETECTING ACETYLATION OF COX2 PROTEIN, AND USES THEREOF
#8 | 2022-05-05METHOD FOR TREATING A DEGENERATIVE NEUROLOGICAL DISORDERS COMPRISING ADMINISTERING ASM INHIBITOR
#9 | 2021-09-02COMPOSITION FOR DIAGNOSING DISEASES ASSOCIATED WITH COX2 OVEREXPRESSION AND SCREENING METHOD THEREFOR
#10 | 2021-06-242-AMINO-2-(1,2,3-TRIAZOLE-4-YL)PROPANE-1,3-DIOL DERIVATIVE OF NOVEL COMPOUND FOR DIRECTLY INHIBITING ASM ACTIVITY, AND USE THEREOF
#11 | 2021-03-25Pharmaceutical composition for preventing or treating degenerative brain disorders including HDL-APOM-S1P as active ingredient
#12 | 2021-03-11Phenylsulfonyl oxazole derivative and use thereof
#13 | 2021-01-07Composition for diagnosis of degenerative neurological diseases
#14 | 2021-01-07Pharmaceutical composition for preventing or treating neurodegenerative diseases comprising COX2 acetylating agent as active ingredient
#15 | 2020-11-12PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASE, CONTAINING, AS ACTIVE INGREDIENTS, CYCLODEXTRIN AND STEM CELLS IN WHICH VEGF IS OVEREXPRESSED
#16 | 2020-08-13Method for treating a neurological disorder comprising administering ASM inhibitors
#17 | 2020-06-04Neuropeptide Y fragment capable of releasing hematopoietic stem cells into blood and treating osteoporosis
#18 | 2020-03-12Amyotrophic lateral sclerosis diagnostic composition using acid sphingomyelinase, and method for detecting diagnostic markers
#19 | 2019-01-31Pharmaceutical composition containing stem cell in which vascular endothelial growth factor is overexpressed as effective ingredient for preventing or treating neurodegenerative disease
#20 | 2018-09-20Method for treating a degenerative neurological disorders comprising administering ASM inhibitor
#21 | 2017-09-21Peptides for treating bone diseases and use thereof
#22 | 2017-08-10Method using an Y1 receptor activator for treating an anticancer agent-induced nephrotoxic injury
#23 | 2017-08-08Method for treating a neurodegenerative disease or depression comprising administering derivatives of 2-amino-2-(1-dodecyl-1H-1,2,3-triazol-4-yl)propane-1,3-diol
#24 | 2017-07-06Composition containing neuropeptide Y for inhibiting side effects of anticancer agents
#25 | 2017-06-29NOVEL PEPTIDES FOR PREVENTING OR TREATING BONE DISEASES AND USE THEREOF
#26 | 2017-03-23Peptides for preventing or treating bone diseases and use thereof
#27 | 2017-03-23Novel Peptides for Preventing or Treating Bone Diseases and Use Thereof
#28 | 2016-08-25Pharmaceutical composition for preventing or treating osteoporosis which comprises neuropeptide Y as active ingredient
#29 | 2016-04-14Composition comprising ASM inhibitor as active ingredient for preventing or treating degenerative neurological disorders
#30 | 2016-03-24Composition Comprising AMD3100 For Preventing or Treating Bone Diseases
#31 | 2013-08-29COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES CONTAINING CCL5
#32 | 2012-11-15Peptide which passes through blood-brain barrier and targets apoptosis of neurodegenerative brain disease site and uses thereof
416153 ⎘